Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Craig A. Sponseller"'
Autor:
Kathleen V. Fitch, Emma M. Kileel, Sara E. Looby, Markella V. Zanni, Laura R. Sanchez, Carl J. Fichtenbaum, Edgar T. Overton, Carlos Malvestutto, Judith A. Aberg, Karin L. Klingman, Beverly Alston-Smith, Judith Lavelle, Anne Rancourt, Sharlaa Badal-Faesen, Sandra Wagner Cardoso, Anchalee Avihingsanon, Sandesh Patil, Craig A. Sponseller, Kathleen Melbourne, Heather J. Ribaudo, Katharine Cooper-Arnold, Patrice Desvigne-Nickens, Udo Hoffmann, Pamela S. Douglas, Steven K. Grinspoon, on behalf of the REPRIEVE Investigators
Publikováno v:
HIV Research & Clinical Practice, Vol 21, Iss 1, Pp 11-23 (2020)
Background: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) is a multicenter, randomized, placebo-controlled trial, designed to test whether a statin medication can prevent cardiovascular disease in people with HIV. REPRIEVE recentl
Externí odkaz:
https://doaj.org/article/c1bbcd7120594120b0af18d8c43b3e8f
Autor:
Mabel Toribio, Kathleen V. Fitch, Lauren Stone, Markella V. Zanni, Janet Lo, Chris de Filippi, Craig A. Sponseller, Hang Lee, Ida Grundberg, Melanie A. Thompson, Judith A. Aberg, Steven K. Grinspoon
Publikováno v:
EBioMedicine, Vol 35, Iss , Pp 58-66 (2018)
Background: People with HIV (PWH) demonstrate increased cardiovascular disease (CVD), due in part to increased immune activation, inflammation, and endothelial dysfunction. Methods: In a randomized trial (INTREPID), 252 HIV-infected participants with
Externí odkaz:
https://doaj.org/article/6a757553e0ae43bf8b9539fe4f0af29f
Autor:
Judith Lavelle, Katharine Cooper-Arnold, Craig A. Sponseller, Pamela S. Douglas, Sara E. Looby, Anne Rancourt, Heather J. Ribaudo, Udo Hoffmann, Laura Sanchez, Anchalee Avihingsanon, Carlos Malvestutto, Kathleen Melbourne, Karin L. Klingman, Kathleen V. Fitch, Sandesh Patil, Sharlaa Badal-Faesen, Beverly Alston-Smith, Reprieve Investigators, Emma M Kileel, Steven K. Grinspoon, Judith A. Aberg, Sandra W. Cardoso, Carl J. Fichtenbaum, Edgar T. Overton, Patrice Desvigne-Nickens, Markella V. Zanni
Publikováno v:
HIV Res Clin Pract
BACKGROUND: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) is a multicenter, randomized, placebo-controlled trial, designed to test whether a statin medication can prevent cardiovascular disease in people with HIV. REPRIEVE recentl
Autor:
Udo Hoffmann, Maria Saumoy, Heather J. Ribaudo, Kiat Ruxrungtham, Triin Umbleja, Pamela S. Douglas, Craig A. Sponseller, Gerald S. Bloomfield, Vicente Estrada, Carl J. Fichtenbaum, Markella V. Zanni, Edgar T. Overton, Judith S. Currier, Kathleen V. Fitch, Judith A. Aberg, Ann Marie Navar, Steven K. Grinspoon, Flavio Bustorff, Anchalee Avihingsanon, Emma M Kileel, Reprieve Investigators, Kathleen Melbourne
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 73, iss 11
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background In addition to traditional cardiovascular (CV) risk factors, antiretroviral therapy, lifestyle, and human immunodeficiency virus (HIV)-related factors may contribute to future CV events in persons with HIV (PWH). Methods Among participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::523de4e98fcd58bc87a30eaecd701329
https://escholarship.org/uc/item/39g8z3x3
https://escholarship.org/uc/item/39g8z3x3
Autor:
Carl J. Fichtenbaum, Markella V. Zanni, Craig A. Sponseller, Michael T. Lu, Steven K. Grinspoon, Judith A. Aberg, Pamela S. Douglas, Katharine Cooper-Arnold, Myron A. Waclawiw, Beverly Alston-Smith, Heather J. Ribaudo, Karin L. Klingman, Carlos Malvestutto, Udo Hoffmann, Judith S. Currier, Kathleen V. Fitch, Patrice Desvigne-Nickens, Edgar T. Overton
Publikováno v:
Am Heart J
Cardiovascular disease (CVD) is more frequent among people with HIV (PWH) and may relate to traditional and nontraditional factors, including inflammation and immune activation. A critical need exists to develop effective strategies to prevent CVD in
Autor:
Marije van Schalkwyk, Edgar T. Overton, Steven K. Grinspoon, Nagalingeswaran Kumarasamy, Carl J. Fichtenbaum, Janet Lo, Judith A. Aberg, Esteban Martínez, Judith S. Currier, Patrice Desvigne-Nickens, Craig A. Sponseller, Breno Santos, Markella V. Zanni, Sue Siminski, Gerald S. Bloomfield, Pamela S. Douglas, Heather J. Ribaudo, Kathleen Melbourne, Kathleen V. Fitch, Yvetot Joseph, Jorge Leon-Cruz, Carlos Malvestutto, Reprieve Investigators, Emma M Kileel, Udo Hoffmann
Publikováno v:
J Infect Dis
The Journal of infectious diseases, vol 222, iss Suppl 1
The Journal of infectious diseases, vol 222, iss Suppl 1
Background Patterns of antiretroviral therapy (ART) use and immunologic correlates vary globally, and contemporary trends are not well described. Methods The REPRIEVE trial (Randomized Trial to Prevent Vascular Events in HIV) enrolled persons with hu
Autor:
Janet Lo, Markella V. Zanni, Chris deFilippi, Kathleen V. Fitch, Emmett Sprecher, Takara L. Stanley, Laurie R. Braun, Ruslan I. Sadreyev, Melanie A. Thompson, Craig A. Sponseller, Ida Grundberg, Steven K. Grinspoon, Hang Lee, Lai Ping Wong, Narges Rashidi, Diana Cagliero, Judith A. Aberg, Mabel Toribio
Publikováno v:
J Infect Dis
Background People with human immunodeficiency virus (PWH) demonstrate increased atherosclerotic cardiovascular disease (ASCVD). Statins are being studied to prevent ASCVD in human immunodeficiency virus (HIV), but little is known regarding the effect
Autor:
Markella V. Zanni, Michael T. Lu, Kenneth C. Williams, Júlia Karády, Edgar T. Overton, Carl J. Fichtenbaum, Susan L. Koletar, Cornelius N Van Dam, Udo Hoffmann, Jana Taron, Judith A. Aberg, Emma M Kileel, Pamela S. Douglas, Thomas Mayrhofer, Michelle Floris-Moore, Borek Foldyna, Steven K. Grinspoon, Reprieve trial, Heather J. Ribaudo, Craig A. Sponseller, Tricia H. Burdo, Kathleen V. Fitch, Judith S. Currier, Michael C. Keefer, Bingxue K Zhai, Carlos Malvestutto, Kathleen Melbourne
Publikováno v:
JAMA Network Open
Key Points Question What is the extent of coronary artery disease among people with well-controlled HIV and low to moderate risk of atherosclerotic cardiovascular disease (ASCVD), and how is coronary artery disease associated with traditional risk, i
Autor:
Douglas J. Ward, Melanie A. Thompson, Stuart E. Campbell, Craig A. Sponseller, Vladimir A. Kryzhanovski, Judith A. Aberg
Publikováno v:
The Lancet HIV. 4:e284-e294
People living with HIV-1 infection are at greater risk for cardiovascular disease than seronegative adults. Treatment of dyslipidaemia with statins has been challenging in people with HIV because of an increased potential for drug interactions due to
Autor:
Seth S. Martin, Peter P. Toth, Krishnaji R. Kulkarni, Joseph M. Massaro, Ralph B. D'Agostino, Steven R. Jones, Parag H. Joshi, P. Elliott Miller, Craig A. Sponseller
Publikováno v:
AIDS. 31:965-971
OBJECTIVE Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in those with HIV. An emerging CVD risk factor is triglyceride-rich remnant lipoprotein cholesterol (RLP-C: the sum of intermediate-density lipoprotein and very low-